Search Results
Phase II trial of sorafenib plus standard therapy in newly diagnosed acute myeloid leukaemia
Phase II trial of sorafenib plus standard therapy in newly diagnosed acute myeloid leukaemia
Updated results from the SORAML trial of sorafenib in younger patients with newly diagnosed AML
Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
ASH2014: Christoph Röllig - SAL-Soraml Trial
Crenolanib plus 7+3 chemotherapy in adults with newly diagnosed FLT3-mutated AML.
FLT3 Inhibitors in the Therapy of Acute Myeloid Leukemia
Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia
Gilteritinib plus azacitidine versus azacitidine monotherapy for newly diagnosed FLT3-mutated AML
New Frontiers and Emerging Treatments for Acute Myeloid Leukemia | Webcast
RATIFY Trial: Midostaurin’s Role in Treating AML
Quizartinib improves overall survival in adult patients with FLT3-ITD+ acute myeloid leukaemia
